Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naranjan S Dhalla

Showing results (11-20 of 197) with videos related to

Pageof 20
Sort By:
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Protein Kinases as Drug Development Targets for Heart Disease TherapyNaranjan S Dhalla, Alison L Müller
Canadian Journal of Physiology and Pharmacology|September 25, 2023
Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failureSukhwinder K Bhullar, Naranjan S Dhalla
Cells|August 26, 2022
Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic ResponseParamjit S Tappia, Naranjan S Dhalla
American Journal of Physiology. Heart and Circulatory Physiology|July 25, 2006
Modification of intracellular calcium concentration in cardiomyocytes by inhibition of sarcolemmal Na+/H+ exchangerHarjot K Saini, Naranjan S Dhalla
Experimental and Clinical Cardiology|January 26, 2011
Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failureNavneet S Rehsia, Naranjan S Dhalla
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 3, 2004
Carnitine palmitoyltransferase-I, a new target for the treatment of heart failure: perspectives on a shift in myocardial metabolism as a therapeutic interventionSushma A Mengi, Naranjan S Dhalla
Heart Failure Reviews|September 19, 2009
Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failureNavneet S Rehsia, Naranjan S Dhalla
Canadian Journal of Physiology and Pharmacology|April 16, 2010
Ischemia-reperfusion-induced changes in sarcolemmal Na+/K+-ATPase are due to the activation of calpain in the heartRaja B Singh, Naranjan S Dhalla
Clinical Chemistry and Laboratory Medicine|January 15, 2013
Mechanisms of the beneficial effects of vitamin B6 and pyridoxal 5-phosphate on cardiac performance in ischemic heart diseaseNaranjan S Dhalla, Satoshi Takeda, Vijayan Elimban
The Canadian Journal of Cardiology|September 15, 2006
Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathiesJarmila Machackova, Judit Barta, Naranjan S Dhalla
Pageof 20

Showing results (11-20 of 197) with videos related to

Sort By:
Pageof 20
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Protein Kinases as Drug Development Targets for Heart Disease TherapyNaranjan S Dhalla, Alison L Müller
Canadian Journal of Physiology and Pharmacology|September 25, 2023
Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failureSukhwinder K Bhullar, Naranjan S Dhalla
Cells|August 26, 2022
Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic ResponseParamjit S Tappia, Naranjan S Dhalla
American Journal of Physiology. Heart and Circulatory Physiology|July 25, 2006
Modification of intracellular calcium concentration in cardiomyocytes by inhibition of sarcolemmal Na+/H+ exchangerHarjot K Saini, Naranjan S Dhalla
Experimental and Clinical Cardiology|January 26, 2011
Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failureNavneet S Rehsia, Naranjan S Dhalla
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 3, 2004
Carnitine palmitoyltransferase-I, a new target for the treatment of heart failure: perspectives on a shift in myocardial metabolism as a therapeutic interventionSushma A Mengi, Naranjan S Dhalla
Heart Failure Reviews|September 19, 2009
Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failureNavneet S Rehsia, Naranjan S Dhalla
Canadian Journal of Physiology and Pharmacology|April 16, 2010
Ischemia-reperfusion-induced changes in sarcolemmal Na+/K+-ATPase are due to the activation of calpain in the heartRaja B Singh, Naranjan S Dhalla
Clinical Chemistry and Laboratory Medicine|January 15, 2013
Mechanisms of the beneficial effects of vitamin B6 and pyridoxal 5-phosphate on cardiac performance in ischemic heart diseaseNaranjan S Dhalla, Satoshi Takeda, Vijayan Elimban
The Canadian Journal of Cardiology|September 15, 2006
Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathiesJarmila Machackova, Judit Barta, Naranjan S Dhalla
Pageof 20